U.S NIPT Test Market is Projected to Grow at a CAGR of 13% by 2031: DPIResearch

DELHI, India - June 19, 2023 - PRLog -- The growth of the market depends on several factors, including the increase in the incidence of chromosomal aneuploidies in fetuses, the progress of advanced non-invasive prenatal testing products, the increasing acceptance of non-invasive prenatal testing, the growing focus on reimbursement for non-invasive prenatal testing, the rising preference for non-invasive techniques over invasive methods, and the ACOG guidelines recommending NIPT for all pregnancies regardless of risk.

The report on the non-invasive prenatal testing (NIPT) market in the United States is a comprehensive study and presentation of drivers, restraints, opportunities, demand, market size, insights, forecasts, and trends in the non-invasive prenatal testing (NIPT) market in the United States during 2019 – 2031. Furthermore, the report includes historic market data from 2019 to 2022 and forecast until 2031.

Key Players in the United States Non–Invasive Prenatal Testing Market are Listed Below:

• Illumina, Inc.
• Natera, Inc.
• Quest Diagnostics
• Myriad Genetics, Inc.
• Centogene
• GenPath
• PerkinElmer
• Yourgene Health
• Invitae Corporation
• Agilent Technologies
• Ariosa Diagnostics (Roche)
• Laboratory Corporation of America Holdings(Labcorp)

Download Exclusive Free Sample of Report: https://dpiresearch.com/reports/united-states-non-invasiv...